These results, along with a preceding report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two support the strategy of focusing on ACKR3 as a novel method to modulate the opioid method, which could open up new therapeutic avenues for opioid-related Issues. Improve much healthier immune https://samuelv849pgw5.actoblog.com/profile